(Q36602277)

15 August 2017

1 reference

title

Particulate delivery systems for animal vaccines (English)

1 reference

Jean-Pierre Y Scheerlinck

15 August 2017

author

series ordinal

1

1 reference

15 August 2017

Deanne L V Greenwood

2

1 reference

15 August 2017

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

40

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

118-124

1 reference

Adjuvants in veterinary vaccines: modes of action and adverse effects

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Vaccines that facilitate antigen entry into dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Improving protein therapeutics with sustained-release formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Biodegradable microspheres in drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Immunization with Staphylococcus aureus lysate incorporated into microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Adjuvants designed for veterinary and human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Recent advances in veterinary vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

ISCOMATRIX adjuvant for antigen delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Induction of lymphocyte recruitment in the absence of a detectable immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Current status and potential application of ISCOMs in veterinary medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Group A rotavirus veterinary vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Development of an antigen presentation system based on plum pox potyvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Virus-like particles as immunogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Efficacy of DNA vaccination by different routes of immunisation in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Expression of naked DNA in human, pig, and mouse skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Reporter gene expression in dendritic cells after gene gun administration of plasmid DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Fish DNA vaccine against infectious hematopoietic necrosis virus: efficacy of various routes of immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Immune responses in sheep after immunization with Toxoplasma gondii antigens incorporated into iscoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Immunogenicity and efficacy of recombinant subunit vaccines against phocid herpesvirus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Protective immunity induced in chicken by a single immunization with Mycoplasma gallisepticum immunostimulating complexes (ISCOMS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Virosome and ISCOM vaccines against Newcastle disease: preparation, characterization and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Cellulose beads bound to cellulose binding domain-fused recombinant proteins; an adjuvant system for parenteral vaccination of fish.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2006.05.023

10.1016/J.YMETH.2006.05.023

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference